Semma Therapeutics Potential Cure For Type 1 Diabetes
Posted by
www.biotecnika.org
Semma Therapeutics Potential Cure For Type 1 Diabetes Harvard
University scientist Douglas Melton was in news back in November 2017
when His startup company Semma Therapeutics, raised $114 million
funding to develop a potential cure for Type 1 diabetes. His prime
idea was to take undifferentiated pluripotent stem cells and turn them
into insulin-producing pancreatic beta cells. But […]
The post Semma Therapeutics Potential Cure For Type 1 Diabetes
appeared first on BioTecNika .
https://www.biotecnika.org/2019/05/semma-therapeutics-potential-cure-for-type-1-diabetes/
Biotech News
Subscribe to:
Post Comments (Atom)
Post a Comment